Inventor

ZABLOCKI MARY-MARGARET

US50 patents

⚠️ This page may combine multiple inventors who share the name “ZABLOCKI MARY-MARGARET”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

ZABLOCKI MARY-MARGARET

FORMA THERAPEUTICS INC

3-aryl bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors

3-aryl-4-amido-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors

3-aryl-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors

3-aryl-4-amido-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors

3-alkyl bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors

3-aryl-4-amido-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors

3-alkyl-4-amido-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors

3-alkyl bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors

3-alkyl bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors

3-alkyl-4-amido-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors

3-alkyl bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors

3-aryl-4-amido-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors

3-aryl-4-amido-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors

3-alkyl bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors

3-alkyl-4-amido-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors

3-alkyl bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors

3-aryl-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors

3-aryl-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors

3-aryl-4-amido-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors

3-alkyl-4-amido-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors

3-alkyl-4-amido-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors

3-alkyl-4-amido-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors

2-spiro-5- and 6-hydroxamic acid indanes as HDAC inhibitors

Alpha-cinnamide compounds and compositions as HDAC8 inhibitors

Alpha-cinnamide compounds and compositions as HDAC8 inhibitors

Alpha-cinnamide compounds and compositions as HDAC8 inhibitors

3-aryl-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors

[6,6] Fused bicyclic HDAC8 inhibitors

Inhibiting fatty acid synthase (FASN)

[6,6] fused bicyclic HDAC8 inhibitors

Inhibiting fatty acid synthase (FASN)

VALO EARLY DISCOVERY INC

3-alkyl bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors

3-aryl-4-amido-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors

3-aryl-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors

3-alkyl-4-amido-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors

2-spiro-5- and 6-hydroxamic acid indanes as HDAC inhibitors

Alpha-cinnamide compounds and compositions as HDAC8 inhibitors

[6,6] fused bicyclic HDAC8 inhibitors

Carboxamides as ubiquitin-specific protease inhibitors

Carboxamides as ubiquitin-specific protease inhibitors

VALO HEALTH INC

3-alkyl bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors

2-spiro-5- and 6-hydroxamic acid indanes as HDAC inhibitors

3-aryl-4-amido-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors

3-alkyl-4-amido-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors

2-spiro-5- and 6-hydroxamic acid indanes as HDAC inhibitors

3-aryl-4-amido-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors

3-aryl-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors

Alpha-cinnamide compounds and compositions as HDAC8 inhibitors

[6,6] fused bicyclic HDAC8 inhibitors

ACCENT THERAPEUTICS INC

Inhibitors of KIF18A and uses thereof